Literature DB >> 18849166

The identification of neurotensin NTS1 receptor partial agonists through a ligand-based virtual screening approach.

Yi Fan1, Margaret H Lai, Kelly Sullivan, Michael Popiolek, Terrance H Andree, Paul Dollings, Mark H Pausch.   

Abstract

We identified small molecule NTS1R agonist compounds through virtual screening of the corporate database using a ROCS approach that searches multi-conformer representations efficiently. As a starting point for the ROCS search, we used the known NTS1R selective antagonist, SR-48527, based on the hypothesis that NT agonists and antagonists might share similar binding regions. Conformations were expanded and selected as database search queries based on a cluster analysis. The search provided us with virtual hits that were tested in intracellular calcium mobilization assays of NTS1R agonist and antagonist activities measured in FLIPR format as well as in [(3)H]NT competition binding studies. The results indicated that two initial hits produced partial agonist activity with potency in the moderate micromolar range.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18849166     DOI: 10.1016/j.bmcl.2008.09.075

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  9 in total

1.  Crystal structure-based virtual screening for fragment-like ligands of the human histamine H(1) receptor.

Authors:  Chris de Graaf; Albert J Kooistra; Henry F Vischer; Vsevolod Katritch; Martien Kuijer; Mitsunori Shiroishi; So Iwata; Tatsuro Shimamura; Raymond C Stevens; Iwan J P de Esch; Rob Leurs
Journal:  J Med Chem       Date:  2011-11-07       Impact factor: 7.446

2.  Imidazole-derived agonists for the neurotensin 1 receptor.

Authors:  Paul M Hershberger; Michael P Hedrick; Satyamaheshwar Peddibhotla; Arianna Mangravita-Novo; Palak Gosalia; Yujie Li; Wilson Gray; Michael Vicchiarelli; Layton H Smith; Thomas D Y Chung; James B Thomas; Marc G Caron; Anthony B Pinkerton; Lawrence S Barak; Gregory P Roth
Journal:  Bioorg Med Chem Lett       Date:  2013-11-21       Impact factor: 2.823

3.  Discovery of ML314, a Brain Penetrant Non-Peptidic β-Arrestin Biased Agonist of the Neurotensin NTR1 Receptor.

Authors:  Satyamaheshwar Peddibhotla; Michael P Hedrick; Paul Hershberger; Patrick R Maloney; Yujie Li; Monika Milewski; Palak Gosalia; Wilson Gray; Alka Mehta; Eliot Sugarman; Becky Hood; Eigo Suyama; Kevin Nguyen; Susanne Heynen-Genel; Stefan Vasile; Sumeet Salaniwal; Derek Stonich; Ying Su; Arianna Mangravita-Novo; Michael Vicchiarelli; Gregory P Roth; Layton H Smith; Thomas D Y Chung; Glen R Hanson; James B Thomas; Marc G Caron; Lawrence S Barak; Anthony B Pinkerton
Journal:  ACS Med Chem Lett       Date:  2013-07-20       Impact factor: 4.345

4.  Discovery of β-Arrestin Biased, Orally Bioavailable, and CNS Penetrant Neurotensin Receptor 1 (NTR1) Allosteric Modulators.

Authors:  Anthony B Pinkerton; Satyamaheshwar Peddibhotla; Fusayo Yamamoto; Lauren M Slosky; Yushi Bai; Patrick Maloney; Paul Hershberger; Michael P Hedrick; Bekhi Falter; Robert J Ardecky; Layton H Smith; Thomas D Y Chung; Michael R Jackson; Marc G Caron; Lawrence S Barak
Journal:  J Med Chem       Date:  2019-08-20       Impact factor: 7.446

5.  Identification of N-{[6-chloro-4-(2,6-dimethoxyphenyl)quinazolin-2-yl]carbonyl}-l-leucine (NTRC-808), a novel nonpeptide chemotype selective for the neurotensin receptor type 2.

Authors:  James B Thomas; Angela M Giddings; Srinivas Olepu; Robert W Wiethe; Danni L Harris; Sanju Narayanan; Keith R Warner; Philippe Sarret; Jean-Michel Longpre; Scott P Runyon; Brian P Gilmour
Journal:  Bioorg Med Chem Lett       Date:  2014-11-24       Impact factor: 2.823

6.  Molecular shape and medicinal chemistry: a perspective.

Authors:  Anthony Nicholls; Georgia B McGaughey; Robert P Sheridan; Andrew C Good; Gregory Warren; Magali Mathieu; Steven W Muchmore; Scott P Brown; J Andrew Grant; James A Haigh; Neysa Nevins; Ajay N Jain; Brian Kelley
Journal:  J Med Chem       Date:  2010-05-27       Impact factor: 7.446

7.  The discovery of indole full agonists of the neurotensin receptor 1 (NTSR1).

Authors:  Paolo Di Fruscia; Yuanjun He; Marcel Koenig; Sahba Tabrizifard; Ainhoa Nieto; Patricia H McDonald; Theodore M Kamenecka
Journal:  Bioorg Med Chem Lett       Date:  2014-06-20       Impact factor: 2.823

8.  The identification of nonpeptide neurotensin receptor partial agonists from the potent antagonist SR48692 using a calcium mobilization assay.

Authors:  James B Thomas; Hernán Navarro; Keith R Warner; Brian Gilmour
Journal:  Bioorg Med Chem Lett       Date:  2009-01-15       Impact factor: 2.823

9.  Identification of N-[(5-{[(4-methylphenyl)sulfonyl]amino}-3-(trifluoroacetyl)-1H-indol-1-yl)acetyl]-l-leucine (NTRC-824), a neurotensin-like nonpeptide compound selective for the neurotensin receptor type 2.

Authors:  James B Thomas; Angela M Giddings; Robert W Wiethe; Srinivas Olepu; Keith R Warner; Philippe Sarret; Louis Gendron; Jean-Michel Longpre; Yanan Zhang; Scott P Runyon; Brian P Gilmour
Journal:  J Med Chem       Date:  2014-08-26       Impact factor: 7.446

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.